Overview
Müllerian aplasia and hyperandrogenism (also known as Müllerian duct aplasia with hyperandrogenism) is an extremely rare condition characterized by the combination of absent or severely underdeveloped Müllerian duct-derived structures (uterus, fallopian tubes, and upper vagina) in 46,XX individuals, along with signs of excess androgen activity. Affected individuals are genetically female but present with primary amenorrhea (absence of menstruation) due to the absence of a functional uterus, while typically having normal female external genitalia and normal ovarian function otherwise. The hyperandrogenism component may manifest as hirsutism (excess body hair), acne, and elevated androgen levels in the blood, which can overlap clinically with features seen in polycystic ovary syndrome (PCOS). This condition affects the reproductive system primarily, with the Müllerian structures failing to develop properly during embryogenesis. The hyperandrogenism suggests an underlying hormonal dysregulation that distinguishes this entity from isolated Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome, which involves Müllerian aplasia without androgen excess. The exact molecular etiology remains poorly understood, though the co-occurrence of these two features suggests a shared developmental or genetic pathway may be disrupted. Diagnosis is typically made during adolescence when affected individuals are evaluated for primary amenorrhea. Imaging studies such as pelvic ultrasound or MRI confirm the absence of the uterus and may reveal normal ovaries. Management is multidisciplinary and may include vaginal dilation therapy or surgical creation of a neovagina to allow sexual intercourse, as well as anti-androgen therapy or other hormonal treatments to manage hyperandrogenism symptoms. Fertility is not possible through natural conception due to the absence of a uterus, though assisted reproductive technologies with gestational surrogacy may be an option for genetic parenthood.
Clinical phenotype terms— hover any for plain English:
Autosomal recessive
Passed on when both parents carry the same gene change; often skips generations
Juvenile
Begins in the teen years
Treatments
No FDA-approved treatments are currently listed for Müllerian aplasia and hyperandrogenism.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Müllerian aplasia and hyperandrogenism at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Müllerian aplasia and hyperandrogenism.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Müllerian aplasia and hyperandrogenism.
Community
No community posts yet. Be the first to share your experience with Müllerian aplasia and hyperandrogenism.
Start the conversation →Latest news about Müllerian aplasia and hyperandrogenism
No recent news articles for Müllerian aplasia and hyperandrogenism.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Müllerian aplasia and hyperandrogenism
What is Müllerian aplasia and hyperandrogenism?
Müllerian aplasia and hyperandrogenism (also known as Müllerian duct aplasia with hyperandrogenism) is an extremely rare condition characterized by the combination of absent or severely underdeveloped Müllerian duct-derived structures (uterus, fallopian tubes, and upper vagina) in 46,XX individuals, along with signs of excess androgen activity. Affected individuals are genetically female but present with primary amenorrhea (absence of menstruation) due to the absence of a functional uterus, while typically having normal female external genitalia and normal ovarian function otherwise. The hyper
How is Müllerian aplasia and hyperandrogenism inherited?
Müllerian aplasia and hyperandrogenism follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Müllerian aplasia and hyperandrogenism typically begin?
Typical onset of Müllerian aplasia and hyperandrogenism is juvenile. Age of onset can vary across affected individuals.